{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:19:12Z","timestamp":1791908352327,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["EB00415"],"award-info":[{"award-number":["EB00415"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK35124"],"award-info":[{"award-number":["DK35124"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK72517"],"award-info":[{"award-number":["DK72517"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008087","name":"Guthy-Jackson Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY13574"],"award-info":[{"award-number":["EY13574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00401-017-1734-6","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T16:51:45Z","timestamp":1496249505000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica"],"prefix":"10.1007","volume":"134","author":[{"given":"Lukmanee","family":"Tradtrantip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"1734_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","volume":"127","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Verkman AS (2014) Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG. Acta Neuropathol 127:539\u2013551","journal-title":"Acta Neuropathol"},{"key":"1734_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.09.010","volume":"254","author":"N Asgari","year":"2013","unstructured":"Asgari N, Khorooshi R, Lillevang ST, Owens T (2013) Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid. J Neuroimmunol 254:76\u201382","journal-title":"J Neuroimmunol"},{"key":"1734_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B (2009) Intrathecal pathogenic anti\u2013aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617\u2013629","journal-title":"Ann Neurol"},{"key":"1734_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66:630\u2013643","journal-title":"Ann Neurol"},{"key":"1734_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1006947322342","volume":"27","author":"DR Brown","year":"1998","unstructured":"Brown DR, Kretzschmar HA (1998) The glio-toxic mechanism of \u03b1-aminoadipic acid on cultured astrocytes. J Neurocytol 27:109\u2013118","journal-title":"J Neurocytol"},{"key":"1734_CR6","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","volume":"286","author":"JM Crane","year":"2011","unstructured":"Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS (2011) Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1\/M23 isoforms and orthogonal arrays. J Biol Chem 286:16516\u201316524","journal-title":"J Biol Chem"},{"key":"1734_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jneumeth.2012.06.017","volume":"209","author":"TA Dincman","year":"2012","unstructured":"Dincman TA, Beare JE, Ohri SS, Whittemore SR (2012) Isolation of cortical mouse oligodendrocyte precursor cells. J Neurosci Methods 209:219\u2013226","journal-title":"J Neurosci Methods"},{"key":"1734_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1084\/jem.132.5.898","volume":"132","author":"O Gotze","year":"1970","unstructured":"Gotze O, Muller-Eberhard HJ (1970) Lysis of erythrocytes by complement in the absence of antibody. J Exp Med 132:898\u2013915","journal-title":"J Exp Med"},{"key":"1734_CR9","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20081241","volume":"205","author":"SR Hinson","year":"2008","unstructured":"Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA (2008) Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 205:2473\u20132481","journal-title":"J Exp Med"},{"key":"1734_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1073\/pnas.1109980108","volume":"109","author":"SR Hinson","year":"2012","unstructured":"Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA (2012) Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 109:1245\u20131250","journal-title":"Proc Natl Acad Sci USA"},{"key":"1734_CR11","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1523\/JNEUROSCI.04-10-02650.1984","volume":"4","author":"S Huck","year":"1984","unstructured":"Huck S, Grass F, Hortnagl H (1984) The glutamate analog \u03b1-aminoadipic acid is taken up by astrocytes before exerting its gliotoxic effect in vitro. J Neurosci 4:2650\u20132657","journal-title":"J Neurosci"},{"key":"1734_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383\u2013392","journal-title":"Nat Rev Neurol"},{"key":"1734_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477","journal-title":"J Exp Med"},{"key":"1734_CR14","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"1734_CR15","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awq177","volume":"133","author":"R Marignier","year":"2010","unstructured":"Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P (2010) Oligodendrocytes are damages by neuromyelitis optic immunoglobulin G via astrocyte injury. Brain 133:2578\u20132591","journal-title":"Brain"},{"key":"1734_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130:1224\u20131234","journal-title":"Brain"},{"key":"1734_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS (2012) Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11:535\u2013544","journal-title":"Lancet Neurol"},{"key":"1734_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3171\/jns.1997.87.2.0294","volume":"87","author":"CC Park","year":"1997","unstructured":"Park CC, Shin ML, Simard JM (1997) The complement membrane attack complex and the bystander effect in cerebral vasospasm. J Neurosurg 87:294\u2013300","journal-title":"J Neurosurg"},{"key":"1734_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/1352458510382324","volume":"16","author":"JD Parratt","year":"2010","unstructured":"Parratt JD, Prineas JW (2010) Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of a perivascular astrocytes. Mult Scler 16:1156\u20131172","journal-title":"Mult Scler"},{"key":"1734_CR20","doi-asserted-by":"publisher","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","volume":"287","author":"PW Phuan","year":"2012","unstructured":"Phuan PW, Ratelade J, Rossi A, Tradtrantip L, Verkman AS (2012) Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays. J Biol Chem 287:13829\u201313839","journal-title":"J Biol Chem"},{"key":"1734_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0165-5728(93)90189-6","volume":"48","author":"SJ Piddlesden","year":"1993","unstructured":"Piddlesden SJ, Morgan BP (1993) Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol 48:169\u2013175","journal-title":"J Neuroimmunol"},{"key":"1734_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","volume":"126","author":"J Ratelade","year":"2013","unstructured":"Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS (2013) Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol 126:699\u2013709","journal-title":"Acta Neuropathol"},{"key":"1734_CR23","doi-asserted-by":"publisher","first-page":"45156","DOI":"10.1074\/jbc.M111.297275","volume":"286","author":"J Ratelade","year":"2011","unstructured":"Ratelade J, Bennett JL, Verkman AS (2011) Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. J Biol Chem 286:45156\u201345164","journal-title":"J Biol Chem"},{"key":"1734_CR24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194\u20131205","journal-title":"Brain"},{"key":"1734_CR25","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/glia.22417","volume":"60","author":"A Rossi","year":"2012","unstructured":"Rossi A, Ratelade J, Papadopoulos MC, Bennett JL, Verkman AS (2012) Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1\/M23 isoform content or supramolecular assembly. Glia 60:2027\u20132039","journal-title":"Glia"},{"key":"1734_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349\u2013361","journal-title":"Brain"},{"key":"1734_CR27","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1073\/pnas.1617859114","volume":"113","author":"SA Sagan","year":"2016","unstructured":"Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, Spencer CM, Ho PP, Bennette JL, Levy M, Levin MH, Verkman AS, Stienman L, Green AJ, Anderson MS, Sobel RA, Zamvil SS (2016) Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proc Natl Acad Sci USA 113:14781\u201314786","journal-title":"Proc Natl Acad Sci USA"},{"key":"1734_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0165-5728(97)00241-5","volume":"84","author":"NJ Scolding","year":"1998","unstructured":"Scolding NJ, Morgan BP, Compston DA (1998) The expression of complement regulatory proteins by adult human oligodendrocytes. J Neuroimmunol 84:69\u201375","journal-title":"J Neuroimmunol"},{"key":"1734_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1083\/jcb.201308118","volume":"204","author":"AJ Smith","year":"2014","unstructured":"Smith AJ, Jin BJ, Ratelade J, Verkman AS (2014) Aggregation state determines the localization and function of M1- and M23-aquaporin-4 in astrocytes. J Cell Biol 204:559\u2013573","journal-title":"J Cell Biol"},{"key":"1734_CR30","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.bpj.2015.10.047","volume":"109","author":"AJ Smith","year":"2015","unstructured":"Smith AJ, Verkman AS (2015) Superresolution imaging of aquaporin-4 cluster size in antibody-stained paraffin brain sections. Biophys J 109:2511\u20132522","journal-title":"Biophys J"},{"key":"1734_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1124\/mol.113.086470","volume":"83","author":"L Tradtrantip","year":"2013","unstructured":"Tradtrantip L, Asavapanumas N, Verkman AS (2013) Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase. Mol Pharmacol 83:1268\u20131275","journal-title":"Mol Pharmacol"},{"key":"1734_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ana.23741","volume":"73","author":"L Tradtrantip","year":"2013","unstructured":"Tradtrantip L, Ratelade J, Zhang H, Verkman AS (2013) Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol 73:77\u201385","journal-title":"Ann Neurol"},{"key":"1734_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ana.22657","volume":"71","author":"L Tradtrantip","year":"2012","unstructured":"Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC, Bennett JL, Verkman AS (2012) Anti\u2013aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 71:314\u2013322","journal-title":"Ann Neurol"},{"key":"1734_CR34","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1096\/fj.11-201608","volume":"26","author":"L Tradtrantip","year":"2012","unstructured":"Tradtrantip L, Zhang H, Anderson MO, Saadoun S, Phuan PW, Papadopoulos MC, Bennett JL, Verkman AS (2012) Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 26:2197\u20132208","journal-title":"FASEB J"},{"key":"1734_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0006-8993(84)90919-3","volume":"308","author":"SG Waxman","year":"1984","unstructured":"Waxman SG, Black JA (1984) Freeze-fracture ultrastructure of the perinodal astrocyte and associated glial junctions. Brain Res 308:77\u201387","journal-title":"Brain Res"},{"key":"1734_CR36","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1523\/JNEUROSCI.20-19-07307.2000","volume":"20","author":"KD Whitney","year":"2000","unstructured":"Whitney KD, McNamara JO (2000) GluR3 autoantibodies destroy neural cells in a complement dependent manner modulated by complement regulatory proteins. J Neurosci 20:7307\u20137316","journal-title":"J Neurosci"},{"key":"1734_CR37","first-page":"140","volume":"76","author":"MG Wing","year":"1992","unstructured":"Wing MG, Zajicek J, Seilly DJ, Compston DA, Lachmann PJ (1992) Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. Immunology 76:140\u2013145","journal-title":"Immunology"},{"key":"1734_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-386043-9.00001-3","volume":"287","author":"H Wolburg","year":"2011","unstructured":"Wolburg H, Wolburg-Buchholz K, Fallier-Becker P, Noell S, Mack AF (2011) Structure and functions of aquaporin-4-based orthogonal arrays of particles. Int Rev Cell Mol Biol 287:1\u201341","journal-title":"Int Rev Cell Mol Biol"},{"key":"1734_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-013-1220-8","volume":"127","author":"C Wrzos","year":"2014","unstructured":"Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Bruck W, Nessler S, Bennett JL, Stadelmann C (2014) Early loss of oligodendrocytes in human and experimental neuromyelitis optic lesions. Acta Neuropathol 127:523\u2013538","journal-title":"Acta Neuropathol"},{"key":"1734_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-016-0309-4","volume":"4","author":"X Yao","year":"2016","unstructured":"Yao X, Su T, Verkman AS (2016) Clobetasol promotes remyelination in a mouse model of neuromyelitis optica. Acta Neuropathol Commun 4:42","journal-title":"Acta Neuropathol Commun"},{"key":"1734_CR41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729\u2013740","journal-title":"Nat Rev Immunol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1734-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1734-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1734-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:47:47Z","timestamp":1589633267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1734-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1734-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,31]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}